Core Insights - American Shared Hospital Services reported a 2.5% increase in revenue for Q3 2025, with a significant 42.3% growth in EBITDA, indicating strong operational performance and efficiency improvements [2][5][10] - The company signed a 10-year extension with an existing health system for the latest model Gamma Knife System, which is expected to drive future revenue growth [3][4] Financial Performance - Q3 2025 revenue reached $7.2 million, up from $7.0 million in Q3 2024, primarily driven by the direct patient care services segment [7][8] - Direct patient care services revenue increased by 9.4% to $4.0 million, representing 56% of total sales, compared to 53% in the prior year [8][9] - Gross margin improved to 22.1%, up 15.8% from the previous year, reflecting higher treatment volumes [9] - Net loss decreased by 91.8% to $17,000 in Q3 2025 from a loss of $207,000 in Q3 2024 [10] Year-to-Date Results - For the first nine months of 2025, revenue increased by 5.6% to $20.4 million compared to $19.3 million in the same period of 2024 [11] - Direct patient care services revenue surged by 36.5% to $10.7 million, driven by new centers in Rhode Island and Puebla, Mexico [12] - Revenue from the equipment leasing segment decreased to $9.7 million, down from $11.5 million, due to lower Gamma Knife volumes [13] Operational Highlights - The company is expanding its footprint in Rhode Island with new radiation therapy centers, which are expected to enhance growth potential [4][6] - Capital expenditures of $7.5 million were made during the nine-month period, contributing to the decrease in cash reserves [17] Balance Sheet Overview - As of September 30, 2025, cash and cash equivalents totaled $5.3 million, down from $11.3 million at the end of 2024 [17] - Shareholders' equity was reported at $24.6 million, or $3.77 per outstanding share, compared to $25.2 million or $3.92 per share at the end of 2024 [17]

Core Points - American Shared Hospital Services (AMS) will hold a conference call on November 13, 2025, at 1:00 PM ET to discuss its third quarter 2025 financial results [2] - The financial results press release will be issued before the market opens on the same day [3] Teleconference and Webcast Information - Domestic callers can dial 1-844-413-3972 and international callers can dial 1-412-317-5776 to join the call [4] - A simultaneous webcast will be available on the company's website [4] - A replay of the call will be accessible until November 20, 2025 [4] Company Overview - AMS is a leading provider of turnkey solutions for cancer treatment centers in North and South America [5] - The company collaborates with health systems to develop cancer service lines and provide integrated care [5] - AMS shares capital investment costs and profitability with its health system partners based on ownership interests [5]